share_log

ArriVent BioPharma | SC 13D: Statement of acquisition of beneficial ownership by individuals-OrbiMed Advisors LLC(9.1%),OrbiMed Capital GP VIII LLC(4.5%), etc.

ArriVent BioPharma | SC 13D:超过5%持股股东披露文件-OrbiMed Advisors LLC(9.1%),OrbiMed Capital GP VIII LLC(4.5%)等

美股sec公告 ·  02/05 16:44
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息